You are reviewing a finding-selection decision made by an earlier agent in the Deep Analysis pipeline. Your job is NOT to change anything — it is to evaluate whether the right three findings were chosen and explain, with specific evidence, where you agree and where you would have chosen differently.

## Context

This pipeline produces "Deep Analysis" documents — concise, high-density intelligence documents designed as cold outreach deliverables for investment banking MDs. The document contains exactly 3 Key Findings selected from 20 tension points identified across a multi-layer research corpus.

The company is **Brimstone Energy** — a pre-revenue industrial technology company that co-produces ASTM C150 portland cement, supplementary cementitious materials, and smelter-grade alumina from calcium silicate rocks.

## Your Inputs

You have three documents to read:

1. **The L3a_select brief** — the selection agent's working notes showing how it scanned all 20 tension points, identified cross-TP threads, scored 8 candidates, and selected 3. This is the decision you are evaluating.
   - File: `outputs/SA_Brimstone_2603182345/l3a_select_brief.md`

2. **The final PDF output (v4)** — the document produced by the full pipeline (L3a_select → L3a_write → L3b → L3c) using the selected findings. Read this to see how the selections materialized in the final deliverable.
   - File: `Brimstone_Deep_Analysis_March_2026_v4.pdf`

3. **An earlier PDF output (v1)** — produced by a different prompt system that selected different findings. This is a comparison baseline. v1 selected: (1) alumina certification gap, (2) CRH as natural buyer / Sublime legal limbo, (3) EGA/Century smelter creates domestic alumina deficit.
   - File: `Brimstone_Deep_Analysis_March_2026.pdf`

Both versions consumed the same underlying L0-L2 research. The difference is entirely in how findings were selected and presented.

## Your Task

### Part 1: Evaluate Each Selected Finding

For each of the 3 findings in v4, answer:

- **Was this the right choice?** Is it genuinely non-obvious, deal-relevant, and well-evidenced?
- **Did the selection brief's reasoning hold up in execution?** Sometimes a finding scores well in the selection matrix but doesn't work as well when written — the compound mechanism is too complex to convey in 350 words, or the evidence turns out to be thinner than the brief suggested.
- **How does it compare to v1's equivalent slot?** What did v4's choice gain and what did it lose?

### Part 2: Evaluate the Cuts

The selection brief explicitly names what it cut and why. For each cut candidate:

- **Was the cut justified?** Or did the brief undervalue a candidate that would have been stronger in the final document?
- **Pay special attention to Candidate E (EGA/Inola standalone).** The brief argues this was "absorbed" into Findings 1 and 3. But v1 ran the EGA/Inola thesis as a standalone Finding 3 and it was arguably the strongest finding in that document — it established the demand side of the alumina thesis (why anyone cares about the alumina at all) with hard numbers ($5B smelter, 1.5M t/yr demand, 180-mile proximity). Evaluate whether absorbing it into two other findings preserved or diluted its impact.

### Part 3: The Finding 3 Question

v4's Finding 3 is a timing-convergence finding ("Three Clocks, One Window"). One perspective: this is a structural observation rather than a non-obvious discovery — it bundles known catalysts (Sublime collapse, FEED timeline, Series B imminence) into a "you must act by Q3 2026" conclusion. An MD might say "obviously there's a window."

Counter-perspective: the specific interaction between three independent deadlines — and especially the CRH legal constraint (non-compete provisions surviving Sublime's operational collapse) — is genuinely non-obvious, and no individual tension point conveys the compound urgency.

Evaluate this honestly. Would Finding 3's slot be better served by:
- The EGA/Inola standalone thesis (Candidate E)?
- The Amazon dual-consent-event thesis (Candidate D)?
- Something else from the 20 tension points?

Or is Finding 3 actually the right choice, and the issue is just that its title doesn't convey the insight sharply enough?

### Part 4: Portfolio Balance

Step back and evaluate the three findings as a set. The selection principles say the ideal balance is "one diligence/valuation finding, one strategic/buyer finding, one structural/timing finding." The brief self-assessed A=diligence/valuation, B=structural/financing, C=timing/buyer.

- Is this the right portfolio for a cold outreach to a cement/materials MD?
- Would a different combination of three findings produce a stronger document as a whole?
- Does the absence of a standalone buyer-thesis finding (CRH, EGA, or Amrize as a specific target) weaken the document for its intended purpose — which is to make a specific MD want to pick up the phone?

## Output Format

Write this as an analytical memo. Prose with headers. Quote specific passages from the selection brief, the v4 PDF, and the v1 PDF to ground your claims. Be honest — if the selections were correct, say so. If they weren't, say exactly what you'd change and why.

Do NOT modify any files. This is a read-only analysis.
